Commentary

Commentary: Shifting the care delivery paradigm to diabetes-depression collaborative care models


 

An endocrinologist/diabetologist was also incorporated for consultation when needed. After 12 months, patients in the intervention group had greater reduction in hemoglobin A1c (0.58%), LDL cholesterol (6.9 mg/dL), systolic blood pressure (5.1 mm Hg), and depression scores than did those in the usual care group. Patients in the intervention group were also more likely to have adjustments made to insulin, antihypertensive medications, and antidepressants.

The success of this intervention, known as TEAMCare, highlights the critical need to incorporate mental health care into primary care and endocrinology practice. Currently, psychiatric and psychological care are largely administered separately from medical care for diabetes, despite evidence showing the success of an integrated care delivery model. In order to address the important interaction between mental health disorders, such as depression, and diabetes, it is critical that evaluation and treatment of mental health be integrated into medical practice.

What can we – endocrinologists and psychiatrists – do to facilitate adoption of such models? First, we can lobby our health systems to support reorganization of our health care delivery approach for patients with comorbid depression and diabetes so that endocrinologists, psychiatrists, and behavioral specialists are incorporated into primary care practices. This will facilitate better alignment of specialists and primary care providers and also enable patients to receive care in a clinical environment where they are most comfortable and have established relationships. Instead of the primary care physician referring the patient separately to psychiatry and endocrinology and awaiting feedback, which can sometimes take several weeks, the psychiatrist and endocrinologist would meet weekly with the primary care physician and nurse case manager team to review the entire patient panel, make timely adjustments in diabetes and antidepressant medications, and recommend behavioral therapy. This population health strategy would enable our two specialties to make a greater impact on a larger number of patients than we can in a half-day clinic session.

Second, our other critical role is to collaborate with payers to develop a sustainable financial reimbursement model to support the psychiatrist and endocrinologist in this novel health care delivery approach, which departs from the traditional fee-for-service model.

Recommended Reading

VIDEO: Meta-analysis: Mortality, safety data may favor SGLT2 inhibitors in T2DM
MDedge Family Medicine
ACP issues 4 statements on T2DM treatment targets
MDedge Family Medicine
‘Fast food swamps’ linked to type 1 diabetes
MDedge Family Medicine
MDedge Daily News: Which diabetes drug boosts survival best?
MDedge Family Medicine
Targeting obesity could slow brain aging in psychosis
MDedge Family Medicine
Nitric oxide–generating dressing holds promise for diabetic foot ulcers
MDedge Family Medicine
Artificial pancreas treatment improves glycemic control in T1DM: Meta-analysis
MDedge Family Medicine
MDedge Daily News: Physician burnout needs more than yoga
MDedge Family Medicine
Hormone therapy raises diabetes risk in breast cancer survivors
MDedge Family Medicine
Metabolic syndrome scoring system predicts CVD in type 2 diabetes
MDedge Family Medicine